Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

PaperCitations, authors & open-access status

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 98 citations, 2011 year and closed oa status.

98
Citations
2011
Year
closed
OA Status

Related on ScholarIQ

Jong‐Mu Sun
Author
Jin Seok Ahn
Author
Lung Cancer
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Research Studies
Topic
470M+ articles · free account